Previous Page  28 / 50 Next Page
Information
Show Menu
Previous Page 28 / 50 Next Page
Page Background

26

Contenido disponible en

www.neumologia-pediatrica.cl

5. Hilton JM, Fitzgerald DA, Cooper DM. Respiratory morbidity of

hospitalized children with Trisomy 21. J Paediatr Child Health 1999;

35: 383-6.

6. Howenstine MS. Problemas pulmonares. En: Pueschel SM,

Pueschel JK, editores. Síndrome de Down. Problemática

biomédica. Barcelona: Masson; 1994. p. 113-27.

7. Chaushu S, Yefenof E, Becker A, Shapira J, Chaushu G. A link

between parotid salivary Ig level and recurrent respiratory

infections in young Down's syndrome patients. Oral Microbiol

Immunol 2002; 17: 172-6.

8. Shah PS, Hellmann J, Adatia I. Clinical characteristics and follow up

of Down syndrome infants without congenital heart disease who

presented with persistent pulmonary hypertension of newborn. J

Perinat Med 2004; 32: 168-70.

9 . Deerojanawong J,Chang AB, Eng PA, Robertson CF, Kemp AS.

Pulmonary diseases in children with severe combined immune

deficiency and DiGeorge syndrome. Pediatr Pulmonol 1997; 24:

324-30.

10. Bertrand P, Navarro H, Caussade S, Holmgren N, Sanchez J.

Airway anomalies in children with Down syndrome: endoscopic

findings. Pediatr Pulmonol 2003; 36.

11. Hilton JM, Fitzgerald DA, Cooper DM. Respiratory morbidity of

hospitalized children with trisomy 21. J Paediatr Child Health 1999;

5: 383-6.

12. Bruijn M, van der Aa LB, van Rijn RR, Bos AP, van Woensel JB. High

incidence of acute lung injury in children with Down syndrome.

Intensive Care Med 2007; 33: 2179-82.

13. Dyce Gordon E, Betharte Sotomayor Y, Dyce Gordon B.

Infecciones respiratorias en niños con síndrome de Down. Revista

Archivo Médico de Camagüey 1997; 1: 1025-55.

14. Shott SR. Down syndrome: common otolaryngologic mani­

festations. Am J Med Genet C Semin Med Genet 2006; 142:

131-40.

15. Brumbaugh DE, Accurso FJ. Persistent silent aspiration in a child

with Trisomy 21. Curr Opin Pediatr 2002; 14: 231-3.

16. Pirez MC, Berrondo C, Giacometti M, et al. Neumonía bacteriana

adquirida en la comunidad en niños hospitalizados. Arch Pediatr

Urug 2003; 74: 6-14.

17. Martin TR, Nakamura M, Matute-Bello G. The role of apoptosis in

acute lung injury. Crit Care Med 2003; 31: S184-8.

18. Fumi M, Yoshikawa, Tetsushi Y, Ayano F, et al. Pneumonia with

marked pleural effusion caused by aspergillus infection. Pediatr

Infect Dis J 2006; 25: 186-7.

19. Ribeiro LM, Jacob CM, Pastorino AC, et al. Evaluation of factors

associated with recurrent and/or severe infections in patients with

Down’s syndrome. J Pediatr (Rio J) 2003; 79: 141-8.

20. Lok RK, Harth SC, Thong YH, et al. Inmunoglobulin G subclass

deciency and predisposition to infection in Down’s syndrome.

Pediatr Infect Dis J 1990; 547-51.

21. Nelson W, Vaughan V, Mckoy J. Tratado de pediatría. 6.a ed.

Barcelona: Salvat; 1975. p. 115-7.

22. McElhinney DB, Straka M, Goldmuntz E, et al. Correlation

between abnormal cardiac physical examination and

echocardiographic nding in neonates with Down syndrome. Am

J Med Genet 2002; 113: 238-41.

23. Corretger JM, Bartrons J. Neumonía grave por Mycoplasma

pneumoniae en el síndrome de Down. Revista Médica

Internacional sobre el Síndrome de Down 2000; 4: 33-43.

24. Jeffrey L,Winters BS, William N, et al. Bordetella bronchiséptica

pneumonia in a patient with Down syndrome: A case report and

review. Pediatrics 1992; 89: 1262-5.

25. Simon A, Völz S, Fleischhack G, et al. Human coronavirus OC43

pneumonia in a pediatric cancer patient with Down syndrome and

acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2007; 29:

432-4.

26. Yasui K, Shinozaki K, Nakazawa T, Agematsu K, Komiyama A.

Presenility of granulocytes in Down syndrome individuals. Am J

Med.Genet 1999; 84: 406-412.

27. Cossarizza A, Ortolani C, Forti E, Montagnani G, Paganelli R,

Zannotti M, et al. Age-related expansion of functionally inefficient

cells with markers of natural killer activity in Down's syndrome.

Blood 1991; 77: 1263-70.

28. Larocca LM, Piantelli M, Valitutti S, Castellino F, Maggiano N,

Musiani P. Alterations in thymocyte subpopulations in Down's

syndrome (trisomy 21). Clin. Immunol. Immunopathol 1988; 49:

175-86.

29. Roat E, Prada N, Lugli E, Nasi M, Ferraresi R, Troiano C, et

al. Homeostatic cytokines and expansion of regulatory T cells

accompany thymic impairment in children with Down syndrome.

Rejuvenation Res 2008; 11: 573-83.

30. Cossarizza A, Monti D, Montagnani G, Ortolani C, Masi M,

Zannotti M, et al. Precocious aging of the immune system in Down

syndrome: alteration of B lymphocytes, T-lymphocytes subsets, and

cells with natural killer markers. Am J Med Genet suppl 1990; 7:

213-8.

31. Flórez Beledo J, Figueras Aloy J. Infecciones respiratorias por

el virus respiratorio sincitial: prevención en el síndrome de

Down. Revista Síndrome de Down 2006: Revista española de

investigación e información sobre el Síndrome de Down. 2006;

89: 45-50.

32. Weir K, McMahon S, Barry L, et al. Oropharyngeal aspiration and

pneumonia in children. Pediatr Pulmonol 2007; 42: 1024-31.

Müller R, Schmidt M, Müller KM, et al. Aspiration pneumonia

caused by vertebrae of a dove in a 39 year old patient with.

33. Borbolla L. Un tema de actualidad: El síndrome de Down. Rev

Cubana Pediatr 1988; 60: 1078-87.

Neumol Pediatr 2013; 8 (1): 22-26.

Infecciones respiratorias en niños con síndrome de Down - M. García et al